1.03 USD
↗ 0.03 (2.70%)PRE MARKET (AS OF 08:01 AM EDT)
Shares of Curis Inc (CRIS) are trading at $1.03. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 18, 2026.
Open?$1.06
High?$1.15
Low?$1.03
Prev. Close?$1.00
Volume?9.8K
Avg. Volume?278.1K
VWAP?$1.08
Rel. Volume?0.04x
Bid / Ask
Bid?$0.88 × 100
Ask?$1.22 × 100
Spread?$0.34
Midpoint?$1.05
Valuation & Ratios
Market Cap?2.4M
Shares Out?2.1M
Float?35.3M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?0.52
EPS?-$8.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Themes
Employees
24
Market Cap
2.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2000-08-01
Address
128 SPRING STREET
LEXINGTON, MA 02421
Phone: 617-503-6500
LEXINGTON, MA 02421
Phone: 617-503-6500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-96.11Distress
Confidence?43%Low
Short InterestLow
Short % of Float?0.48%Low
Short Interest?168.2K
Days to Cover?1.0
Free Float35.3M
Avg Daily Volume177.2K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.49Weak
Quick Ratio?0.49Weak
Cash Ratio?0.37Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.52CHEAP▾
Peers100
S&P97
P/S?0.56CHEAP▾
Peers100
S&P95
P/FCF?N/A▾
EV/EBITDA?0.3CHEAP▾
Peers100
S&P97
EV/Sales?-0.61CHEAP▾
S&P97
Returns & Efficiency
ROE?-450.5%WEAK▾
S&P3
ROA?-111.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30587000
Enterprise Value?$-2647922
Fundamentals ratios updated end of day